Inventor · disambiguated record
Olivier Labeeuw
Also filed as: LABEEUW OLIVIER
8 granted patents·1 pending application·35 citations·filing 2006–2022
80Inventor score
Files withBIOPROJET SOC CIV4BERREBI-BERTRAND ISABELLE1BERTRAND ISABELLE1BIOPROJECT1BIOPROJET PHARMA1
Top patents by PatentIndex Score
9 records- 0189US9255101B26,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligandsBIOPROJECT·Filed 2013·Granted Feb 9, 2016·25 cites·13 claims
- 0279US9029357B2Benzazole derivatives as histamine H4 receptor ligandsBIOPROJET SOC CIV·Filed 2014·Granted May 12, 2015·4 cites·9 claims
- 0373US8802664B2Benzazole derivatives as histamine H4 receptor ligandsBERREBI-BERTRAND ISABELLE·Filed 2011·Granted Aug 12, 2014·4 cites·11 claims
- 0471US12134608B2Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligandsBIOPROJET SOC CIV·Filed 2022·Granted Nov 5, 2024·0 cites·18 claims
- 0567US8076329B2Histamine H3-receptor ligands and their therapeutic applicationsBERTRAND ISABELLE·Filed 2006·Granted Dec 13, 2011·2 cites·12 claims
- 0656US11306069B2Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligandsBIOPROJET SOC CIV·Filed 2018·Granted Apr 19, 2022·0 cites·13 claims
- 0742US9242959B2(Aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applicationsBIOPROJET SOC CIV·Filed 2013·Granted Jan 26, 2016·0 cites·14 claims
- 0840US11179329B2Therapeutical use of H3-ligandsBIOPROJET PHARMA·Filed 2018·Granted Nov 23, 2021·0 cites·18 claims
- 0933US2012129892A1Novel pharmaceutically acceptable salts of 4-(1h-imidazol-4-ylmethyl)pyridine and their therapeutical usesCAPET MARC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →